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Objective: We report a clinical study on the use of 7.2%, 2400 mOsm/L,
hypertonic saline solution compared with gelatin in early postoperative
period after coronary artery bypass surgery. Methods: Two groups (n 5 10
each) received 5 ml/kg of either saline solution or gelatin over 1 hour.
Cardiac index, central venous pressure, pulmonary capillary wedge pres-
sure, systemic and pulmonary vascular resistance indices, arterial oxygen
tension, plasma osmolarity, electrolytes, and urinary output were recorded
before starting the infusion and subsequently at 10, 30, 60, 90, 120, 240 and
600 minutes. Plasma creatinine, urea, electrolytes, urinary volume, and
sodium excretion were measured at 12 and 24 hours. Results: There were no
significant demographic or operative differences between the groups.
Patients receiving saline solution had a larger diuresis at 12 (p 5 0.0008)
and 24 hours (p 5 0.002), with less positive balance at 12 hours (p 5
0.0008). The group receiving saline solution had better cardiorespiratory
recovery with shorter extubation time (p 5 0.033), and earlier increase in
cardiac index with a positive correlation between plasma sodium content
and cardiac index. Maximum increase in cardiac index (131%) occurred at
60 minutes (p 5 0.025) associated with 8% increase in plasma sodium
content (r 5 0.51, p 5 0.01), without a concomitant rise in pulmonary
capillary wedge pressure. The group receiving gelatin had a linear increase
in cardiac index with increasing pulmonary capillary wedge pressure,
reaching 116% from baseline by 90 minutes. Compared with the gelatin-
treated group, patients receiving saline solution had unchanged systemic
vascular resistance index but a significantly lower pulmonary vascular
resistance index with a negative correlation to plasma sodium content.
There was no difference in levels of urea and creatinine. No side-effect
attributable to the use of saline solution was observed. (J Thorac Cardio-
vasc Surg 1998;115:178-89)
Cardiopulmonary bypass (CPB) is known to pro-duce fluid retention1 and disturbed microcircu-
lation2 along with depressed cardiorespiratory state
for a variable period after the operation. The exact
cause or the changes leading to this state are
unclear.
We have conducted this study with the hypothesis
that during the protracted hypotensive state of CPB,
significant endothelial and visceral edema ensues,
subsequent to the breakdown of energy-dependent
volume-regulatory mechanisms, contributing to
multiorgan dysfunction. Increasing plasma osmolar-
ity with an electrolyte solution (hypertonic saline
solution, HTS) that would not avidly cross into the
intracellular compartment can be expected to os-
motically reverse this presumed intracellular fluid
retention and hence generally improve endothelial,
myocardial, and other visceral function.
Experimental use of hyperosmolar saline solu-
tions is not new. In 1919, Penfield3 described the use
of 2% sodium bicarbonate in hypovolemic dogs. In
1973, Moylan, Reckler, and Mason4 reported the
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usefulness of 1.8% saline solution in the treatment
of patients with shock caused by burns. In 1980, De
Flippe and coworkers,5 using 7.5% HTS, success-
fully treated nine of 12 patients with severe hypo-
volemic shock of varied causes. Since these reports,
interest has been renewed in “small volume resus-
citation” using hyperosmolar salt solutions in the
treatment of trauma,6 during aortic operations,7
during cardiogenic shock,8 and during cardiac anes-
thesia.9 Most of these studies used a mixture of HTS
with a synthetic colloid (dextran or hydroxyethyl
starch). Observations made on infusion of a mixture
of two synergistically active ingredients may have
blurred the effects of HTS alone.
Cross and associates10 have gainfully used weak
HTS (1.8%), comparing it with 0.9% saline solution,
after coronary artery bypass grafting (CABG). How-
ever, the condition of their subjects was hemody-
namically stabilized by means of synthetic colloids
and blood products before the HTS solution was
administered. The role of HTS alone in the early
post-CABG period has not been studied. For the
present study we have used 7.2% HTS, because
when the concentration is above 7.5% not only does
hemolysis occur but the hemodynamic effects pla-
teau as well.11
GEL (gelatin; Haemaccel, Hoechst-Roussel
Pharm, Inc., Somerville, N.J.) is the standard pri-
mary volume expander at our institution; hence it
was used as the control.
Patients and methods
Design: Prospective, randomized, double-blind trial.
The study was approved by the hospital ethical committee
and informed consent was obtained form all patients.
Subjects. The study comprised 20 adult patients under-
going elective CABG. Exclusion criteria were age older
than 75 years, preoperative ejection fraction less than
35%, plasma creatinine content greater than 135 mmol/L,
preoperative angiotensin-converting enzyme inhibitors,
need for inotropic support, and postoperative bleeding
more than 200 ml/hr or necessitating resternotomy for
hemostasis. During the period of the study, all randomly
contacted patients except one consented to participate in
the study. There were no postoperative exclusions.
Methods
Anesthesia and surgery. All operations (CABG) were
performed by a single surgical and anesthetic team. A
thermodilution catheter was inserted before the operation
in all patients. CPB was instituted with a nonpulsatile
pump (Medtronic Bio-Medicus, Eden Prairie, Minn.) and
an Avecor affinity membrane oxygenator (Avecor Cardio-
vascular, Inc., Plymouth, Minn.). The myocardium was
protected by the use of systemic hypothermia to 28° C,
topical ice slush, and intermittent, antegrade, crystalloid
cardioplegia with St. Thomas’ Hospital solution (15 ml/kg)
repeated every 30 minutes at 7 ml/kg. Pump prime
consisted of Hartmann’s solution 500 ml, GEL 500 ml,
20% mannitol 150 ml, and heparin 5000 units given
intravenously. Additional Hartmann’s solution was used
to maintain the reservoir volume at a minimum of 500 ml.
Packed red cells were transfused if the hemoglobin value
was less than 8 gm/dl.
Postoperative fluids. In the intensive treatment unit 4%
dextrose/0.18% saline solution with 20 mmol K1, at a rate
of 1 ml/kg, was given as maintenance fluid. Patients were
assigned to receive 5 ml/kg of either 7.2% HTS (2400
mOsm/L, Na1 and Cl– 1200 mEq/L each) or GEL (Poly-
geline [degraded and modified gelatin, average molecular
weight 30,000] 35 gm, Na1 and Cl– content 145 mEq/L
each, Ca11 6.25 mmol/L, osmolarity 301 mOsm/L) over 1
hour. The fluid was prepared by the pharmacy depart-
ment, and the investigators were blinded to the solution in
use. Additional fluid infusion was administered by the
intensive training unit nurse caring for the patient if the
central venous pressure or pulmonary capillary wedge
pressure fell to 5 mm Hg or if the blood pressure was
below 80/50 mm Hg. The identity code of the solution was
broken at the completion of the study. GEL or packed red
cells, or both (if the hemoglobin value was less than 9
gm/L), were administered to maintain these values.
Ventilation/extubation. Postoperative ventilation was
adjusted to maintain arterial oxygen tension greater than
12 kPa, carbon dioxide tension 4.5 to 5 kPa, and pH
greater than 7.32. Patients were extubated according to
the following criteria: awake, respiratory rate less than 30
breaths/min, inspired oxygen fraction less than 0.5, arterial
oxygen tension more than 10 kPa, tidal volume greater
than 5 ml/kg, arterial carbon dioxide tension less than 5.5
kPa, minimal bleeding (,50 ml/hr), and axillary temper-
ature greater than 36.5° C.
Fluid balance. Intraoperative fluid balance was calcu-
lated as follows: (fluids infused [crystalloid 1 colloid] 1
pump prime 1 cardioplegia 1 blood) 2 (diuresis 1
volume left in the pump 1 volume in the suction’s
reservoir). Insensible losses were not accounted for in
either group.
Measurements and monitoring. Measurements were
made before the start of HTS or GEL infusion (baseline)
and at 10, 30, 60 (end of infusion), 90, 120, 240, 400, and
600 minutes afterward. At each point, the following three
groups of parameters were noted:
1. Hemodynamic parameters: heart rate, blood pres-
sure, central venous pressure, pulmonary capillary wedge
pressure, systemic and pulmonary vascular resistance in-
dices (SVRI and PVRI), and cardiac index (CI)
2. Respiratory parameters: arterial oxygen and carbon
dioxide tensions, bicarbonate and arterial base excess,
inspired oxygen fraction, and minute respiratory volume
3. Metabolic/renal parameters: plasma sodium, potas-
sium, urea, creatinine, glucose, and osmolarity
Urinary output and sodium excretion at 12 and 24 hours
were recorded.
Statistics. The data were analyzed with the use of SPSS
for Windows (version 6) (SPSS, Inc., Chicago, Ill.) and
Microsoft Excel software package (Microsoft Corpora-
tion, Redmond, Wash.). For parameters with multiple
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measurements, two-way analysis of variance was used to
simultaneously evaluate the effects of time and group. The
Spearman test was used for correlation of the parameters
at different time points. Nonserial observations were
compared by means of the Wilcoxon-Mann-Whitney test.
Significance was taken at p , 0.05. Of the measured
parameters, SVRI and CI were found to be significantly
different in the two groups at their baseline values. Hence
these were compared after the raw data had been trans-
formed into values depicting change from their baseline
levels. For example, change in CI at a time point (t) 5 CI
(0) [minus] CI (t), where CI (0) is the baseline value.
Results
The two groups did not differ with regard to the
anesthetic, CPB, and operative techniques. Al-
though the GEL group included three women
whereas the HTS group was all male, no significant
Table I. Demographics
HTS GEL
p ValueMean SEM SD Mean SEM SD
Age (yr) 57.1 2.5 7.8 60.1 2.4 7.8 0.2
Weight (kg) 81.6 3.2 10.2 73.5 3.2 10.2 0.09
BSA (m2) 1.9 0.05 0.2 1.9 0.05 0.2 0.1
EF 54.3 5.7 18.05 63.7 3.7 11.8 0.2
CPB (min) 102 9.2 29.1 112.5 7.1 22.5 0.4
X-clamp (min) 66.2 6.3 19.9 65.8 4.7 14.8 0.7
SEM, Standard error of mean; SD, standard deviation; BSA, body surface area; EF, ejection fraction; CPB, cardiopulmonary bypass time (minutes); X-clamp,
crossclamp time.
Table II. Fluid balance and extubation time
HTS GEL
p ValueMean Median SD Mean Median SD
Intraop. balance 52.6 53.0 24.5 54.2 54.2 23.7 0.8
Blood 4.5 4.0 3.3 5.9 4.25 4.3 0.5
Gelatin 13.0 13.6 7.4 17.3 15.2 8.8 0.3
Crystalloid (dextrose saline) 10.4 10.8 2.3 12.7 12.0 4.6 0.2
12 hr total input 32.9 35.1 10.5 40.8 38.3 13.4 0.2
12 hr chest drainage 4.7 3.7 2.6 5.35 5.0 2.4 0.1
12 hr urinary output 51.25 43.8 18.3 26.5 26.0 9.1 0.0008
24 hr urinary output 66.4 60.3 22.0 39.3 38.8 10.1 0.002
Total output at 12 hr 55.9 46.8 20.28 31.9 31.7 10.6 0.001
12 hr postop. balance 223 226.4 17.6 8.9 8.0 10.1 0.0008
NET balance (intraop. 1 12 hr postop.) 29.6 32.1 18.1 63.1 71.7 23.2 0.007
Extubation time (min) 410.9 405 67.8 625 630 242 0.02
Values are given in milliliters per kilogram of body weight. Boldface type indicates significant p values.
Table III. Plasma and urinary biochemistry
HTS GEL
p ValueMean Median SD Mean Median SD
P. Na1 12 hr 148.6 147.0 4.6 141.7 142.0 2.3 0.0003
P. Na1 24 hr 138.1 138.0 3.9 136.9 136.0 3.8 0.19
P. Urea 12 hr 6.1 6.0 1.2 6.3 5.5 1.8 0.72
P. Urea 24 hr 8.1 6.7 3.4 5.7 6.0 1.3 0.13
P. Creat. 12 hr 104.6 106.0 10.7 96.9 94.0 20.5 0.22
P. Creat. 24 hr 106.4 102.5 16.3 97.4 100.5 18.1 0.32
Ur. Na1 12 hr 533.3 544.5 178.8 181.8 177.5 50.6 0.00009
Ur. Na1 24 hr 188.9 150 108.8 74.3 71.0 22.2 0.0009
P. Na1 12 hr, Plasma sodium at 12 hours (Meq/L); P. Na1 24 hr, plasma sodium at 24 hours (Meq/L); P. Urea 12 hr, plasma urea at 12 hours (mmol/L); P.
Urea 24 hr, plasma urea at 24 hours (mmol/L); P. Creat. 12 hr, plasma creatinine at 12 hours, (mmol/L); P. Creat 24 hr, plasma creatinine at 24 hours (mmol/L);
Ur. Na1 12 hr, urinary sodium excretion at 12 hours (mmol/L); Ur. Na1 24 hr, urinary sodium excretion at 24 hours (mmol/L).
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Fig. 1. Fluid requirement of the two groups, with and without inclusion of the intraoperative fluid balance.
Values depicted are mean 6 standard error of mean. Additional fluid requirement is the sum total of the
volume of the synthetic colloid, blood, and isotonic crystalloid given besides the test/control fluid in the first
12 postoperative hours. Postoperative balance denotes the balance for this postoperative period alone, and
Net balance incorporates the intraoperative fluid balance as well.
Fig. 2. Comparison of the percentage change (from the preoperative value) in the SVRI of the two
groups. Values depicted are mean 6 standard error of the mean.
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Fig. 3. Comparison of the percentage change (from the preoperative value) in the PVRI of the two
groups. Values depicted are mean 6 standard error of the mean.
Fig. 4. Percentage changes from the preoperative value in the CI of the two groups. Note an early and
increasing rise in the CI of the HTS group for the time period of infusion of the HTS solution. Values
depicted are mean 6 standard error of the mean.
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group differences were identified between age,
weight, body surface area, preoperative left ventric-
ular ejection fraction, and intraoperative fluid bal-
ance (Table I).
In the first 12 postoperative hours, all patients in
both groups required additional fluid including
blood and GEL. Although the HTS group required
less additional fluid in the form of blood and gelatin
and the total fluid requirement was less in that
group than in the control group, the differences did
not reach statistical significance (Table II, Fig. 1).
The net fluid balance in the two groups, however,
was significantly different. HTS group had almost
double the amount in urinary output by 12 hours
(51.2 6 5.8 ml/kg vs 26.5 6 2.9 ml/kg; p 5 0.0008)
and achieved a negative balance for that period (–23
ml 6 5.6 ml/kg vs 9 6 3.2 ml/kg; p 5 0.0008). Taking
the intraoperative balance into account as well, the
overall fluid balance at 12 hours was less positive in
the HTS group (29.6 6 5.7 ml/kg vs 63 6 7.3 ml/kg;
p 5 0.007).
The urinary output at 24 hours remained high for
the HTS group (66.4 6 7 ml/kg vs 39 6 3.3 ml/kg;
p 5 0.0029). This diuresis did not affect either
plasma K1 level or further K1 requirement. In fact,
plasma K1 levels generally remained higher, but
within normal limits, in the HTS group. No tachy-
arrhythmia occurred in either group. Only a single
dose of 20 mg furosemide was given to one of the
patients in the GEL group.
Plasma Na1 content and osmolarity were signifi-
cantly higher in the HTS group. Maximum Na1
level in the HTS was 156.9 mEq/L at 60 minutes. At
12 hours, plasma Na1 was significantly higher in the
HTS group (p 5 0.0003), but by 24 hours there was
no difference between the two groups (p 5 0.19).
Urinary excretion of sodium continued to remain
significantly higher in the HTS group until the
24-hour measurements. No significant difference
was noted between the plasma creatinine or urea
levels of the two groups at either 12 or 24 hours
(Table III).
Patients in the HTS group met the extubation
criteria at an earlier time period, and this resulted in
a significantly shorter (p 5 0.029) period of ventila-
tory support.
Fig. 5. Interrelationship of the percentage changes in the pulmonary capillary wedge pressure (PCWP)
and the central venous pressure (CVP) of the two groups. While the GEL group shows a gradual and
parallel rise in the central venous and pulmonary capillary wedge pressures over the observational period,
in the HTS group these parameters have a less escalating trend. Values depicted are mean 6 standard
error of the mean.
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No decrease in the calculated SVRI was noted in
the HTS group of patients. It remained within –3 to
19% of the baseline mean value for the whole
observation period. On the contrary, patients in the
GEL group had a gradual fall in SVRI, reaching
72% of the baseline mean by 10 hours (p 5 0.009,
Fig. 2). In contrast, the GEL group had 19% to
120% higher PVRI at most time points before
reaching the baseline mean value at 10 hours. In the
HTS group, however, PVRI was significantly lower
at 30 minutes (p 5 0.019), 60 minutes (p 5 0.039),
120 minutes (p 5 0.019), and at 4 hours (p 5
0.0059). Peculiarly, no difference was observed at 90
minutes (p 5 0.089) (Fig. 3). PVRI in the HTS
group had a negative correlation with plasma Na1
and osmolarity at 30 minutes (p 5 0.029, r 5 –0.5),
120 minutes (p 5 0.039, r 5 –0.4), and at 4 hours
(p 5 0.0039, r 5 –0.6).
The HTS group showed an early increase in CI,
with significant difference from the baseline (p 5
0.025) at 60 minutes (Fig. 4). Maximum values for
pulmonary capillary wedge pressure and central
venous pressure in the HTS group were 16 and 20
mm Hg, respectively. In the GEL group, similar
values were 17 and 12 mm Hg, respectively. The
GEL group had a time-related increase in the
pulmonary capillary wedge pressure, reaching a
maximum of 170% of baseline at 10 hours, whereas
in the HTS group it reached a maximum of 130% of
the baseline at 4 hours (Fig. 5). The GEL group had
a linear increase in the CI, along with an increase in
the pulmonary capillary wedge pressure, without any
correlation to the plasma Na1 or its osmolarity (Fig.
6). The HTS group, however, had a nonlinear rise in
the CI, with a peak of 131% occurring at 60
minutes, coinciding with 7.5% and 8% increases in
the plasma Na1 and osmolarity, respectively (Fig.
7). A positive correlation between plasma Na1 and
CI was noted at 30 minutes (p 5 0.009, r 5 0.53), 60
minutes (p 5 0.019, r 5 0.51), and 120 minutes (p 5
0.019, r 5 0.5). Again, the correlation was blunted at
90 minutes. After the 60-minute peak, the CI in the
HTS group maintained a plateau of between 120 to
130% above the baseline, closely following the
GEL group.
No untoward metabolic, renal, neurologic, cardio-
vascular, or hematologic effects were seen in any of
the HTS group patients. One patient (GEL group)
Fig. 6. Interrelationship of the percentage changes in the plasma sodium (Na1) levels, pulmonary
capillary wedge pressure (PCWP) and cardiac index (CI) in the GEL group. A clear preload effect of the
infused fluid is evident with parallel increase in the cardiac index along with a concomitant rise in the
pulmonary capillary wedge pressure over time, without any appreciable change in the plasma sodium levels.
Values depicted are mean 6 the standard error of the mean.
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with a severely calcific aorta had a cerebrovascular
accident 36 hours after discharge from the intensive
treatment unit. In another patient from the HTS
group a septic syndrome developed in the intensive
treatment unit. Both had a slow but successful
recovery.
Discussion
The results of this study are in contrast to the
conventional wisdom of the therapy of the failing
heart. It may be that the nostrum of avoiding
administration of extra sodium in this circumstance
is incorrect. In the present study, although the two
groups had similar fluid retention during the oper-
ation, 12 hours after the operation the mean net
fluid balance in the HTS group was less by 33.5
ml/kg (129.57 ml/kg vs 163.08 ml/kg for GEL, p 5
0.007). This difference was mainly due to the extra
diuresis in the HTS patients (p 5 0.00089), rather
than significantly different amounts of postoperative
fluid infusion (p 5 0.29). This “diuresis without
additional fluid requirement” was associated with
improved hemodynamics and respiratory function.
Does this represent a correction of the intracellular
fluid retention that may occur during CPB?
Fluid retention with CPB is estimated to be 800
ml/m2 per hour of CPB time.12 Customarily, this
extra fluid is regarded to be sequestered mainly in
the interstitial part of the extracellular fluid com-
partment.13 Variations in the intracellular water
after CPB and its implication on cardiorespiratory
function are not known. Direct measurement of
intracellular water is difficult; measurements are
derived by subtracting extracellular fluid volume
from total body water. However the isotopes most
commonly used for estimation of extracellular fluid
volume, Br82 and S35, do penetrate the cells. Breck-
enridge, Digerness, and Kirklin,13 using inulin,
which does not cross into the cells, have found a
smaller increase in the Br82 space as compared with
inulin space (118.6% vs 133%). This observation
highlights the uncertainty regarding measurement
of the exact amount of the fluid retained in different
body compartments after CPB.
On the other hand, there is evidence to suggest
that CPB may increase intracellular water content.
Fig. 7. Interrelationship of the percentage changes in the plasma sodium (Na1) levels, pulmonary
capillary wedge pressure (PCWP) and cardiac index (CI) in the HTS group. Note the early rapid increase
in the cardiac index along with concomitant rise in the plasma sodium levels in the presence of relatively
stable and lower pulmonary capillary wedge pressures, possibly exhibiting an inotropic effect of HTS-
induced hypernatremia. Values depicted are mean 6 standard error of the mean.
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Generalized capillary endothelial swelling has been
documented after CPB.14 Similarly, intracellular
fluid retention is noted to occur during protracted
low perfusion, situations that essentially mimic a
CPB state (for example, hemorrhagic shock15) and
after major operations.16
If a significant increase in intracellular water
content with visceral and endothelial edema contrib-
utes to postoperative multiorgan dysfunction, then
the choice of volume replacement fluid may be very
important. A medium would be desirable that can
translocate volume from intracellular fluid and the
extracellular fluid and encourage its excretion. In
this regard, HTS and colloids differ in their target
area for mobilization of fluid.
Colloids move water from the interstitium into
the intravascular compartment, whereas HTS shifts
water out of the intracellular compartment.17 The
reason is that the cell membrane restricts free
movement of electrolytes whereas the capillary en-
dothelium is freely permeable to Na1 and Cl–.18
Along with this fluid shift, direct renal vasodilatation
and increased glomerular filtration rate seen with
HTS19 should make it more useful in the post-CPB
period.
HTS has a threefold to sevenfold plasma volume
expansion effect as compared with a 1:1 effect of the
synthetic colloids. Besides, the speed with which
HTS expands plasma volume is almost five and ten
times faster than that of synthetic colloids and
isotonic saline solution, respectively.18, 20
HTS infusion produces a sudden increase in the
plasma osmolarity, which leads to quick efflux of
fluid, first out of the cells that are contiguous with
the plasma (that is, red blood cells and the capillary
endothelium) and then from the interstitium. Cap-
illary endothelium is freely permeable to Na1 and
Cl–, and within 30 minutes the interstitial space
establishes sodium equilibration with the plasma.18
Unlike capillary endothelium, the tissue cells restrict
free movement of electrolytes and hence steadily
give up water as the interstitial sodium concentra-
tion rises. By the time extracellular fluid comes into
new salt equilibrium, it is estimated that the intra-
cellular fluid has a net volume deficit of approxi-
mately 3% to 6%, which is gained by plasma and the
interstitial space in almost equal ratios.18, 21 Such
osmotic translocation of intracellular water is noted
to improve cardiac compliance.18 Besides, there are
reports that HTS has a direct inotropic effect on
myocardium22 and improves microcirculatory flow
as a result of hemodilution, decreased capillary
hydraulic resistance, and improved red blood cell
rheology.23
In summary, the patients receiving HTS were
extubated significantly earlier than those receiving
conventional fluid replacement with a synthetic col-
loid. A decrease in the need for inotropic drugs and
a decrease in PVRI were also noted. These data may
support the hypothesis that generalized intracellular
edema contributes to post-CPB multiorgan dysfunc-
tion and that there is therefore a role for HTS in
counteracting this complication.
A larger sample, with measurement of intracellu-
lar water content, would be required to validate this
hypothesis. From these preliminary data, however, it
would be tempting to observe the cardiopulmonary
effects of hypernatremic hyperosmolarity if it is main-
tained at or above 8% by continuous infusion of HTS.
We believe that HTS has a beneficial role to play
in CPB-based procedures. Its use as an addition to
pump prime, postoperative fluid replacement, and
in situations of multiorgan dysfunction after CPB
need further evaluation.
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Appendix Fig. 1. Fluid balance and extubation time (median values).
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Appendix Fig. 2. Median (left) and mean (right) extubation times.
Appendix Fig. 3. Scatter plots of extubation time (top) and urinary output (bottom).
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Appendix Fig. 4. Scatter plot for postoperative fluid balance.
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